Sort
130,381 grants matching “hiv”
Molecular investigations of HIV-1 maturation pathways and inhibitor actions in situ
$859,992Yong Xiong · Yale University · R01 · FY2025 · AI
Nucleoside modified mRNA based HIV vaccine
$859,974Drew Weissman · University Of Pennsylvania · R01 · FY2016 · AI
A systems biology approach to fingerprint HIV immune defense in Elite Controllers
$859,884Xu Yu · Massachusetts General Hospital · R01 · FY2016 · HL
Neighborhoods, Networks, and the HIV Care Continuum among HIV-infected MSM in NYC
$859,867Hong Van Nhu Tieu · New York Blood Center · R01 · FY2020 · MH
The regulatory role of natural progesterone in barrier immunity
$859,848Florian Hladik · University Of Washington · R01 · FY2024 · AI
Population genotyping of the germline immunoglobulin repertoire in AIDS-designated rhesus macaque breeding colonies
$859,777Steven Edward Bosinger · Emory University · R24 · FY2024 · AI
Population genotyping of the germline immunoglobulin repertoire in AIDS-designated rhesus macaque breeding colonies
$859,777Steven Edward Bosinger · Emory University · R24 · FY2023 · AI
Population genotyping of the germline immunoglobulin repertoire in AIDS-designated rhesus macaque breeding colonies
$859,777Steven Edward Bosinger · Emory University · R24 · FY2022 · AI
Effect of estrogen replacement on postmenopausal ART-associated comorbidity and viral latency
$859,653Paul Kievit · Oregon Health & Science University · R01 · FY2022 · AG
URBAN CONGREGATIONS' CAPACITY FOR HIV PREVENTION & CARE
$859,619Kathryn Pitkin Derose · Rand Corporation · R01 · FY2007 · HD
Eliciting Broadly Neutralizing Antibody Responses against HIV-1 Fusion Peptide Epitope by AB Toxin B Subunit-Based Immunogens
$859,597Xiangpeng Kong · New York University School Of Medicine · R01 · FY2024 · AI
Targeted genetic engineering of B cells to induce protective antibody responses to viral pathogens
$859,486Jennifer Eileen Adair · Fred Hutchinson Cancer Center · R01 · FY2023 · AI
Reducing Latent Viral Reservoirs in Infant Macaques
$859,479Nancy Logan Haigwood · Oregon Health & Science University · R01 · FY2024 · HD
Investigating the Protective Efficacy of SIV/HIV T and B cell Immunity Induced by ChAd and mRNA
$859,455Gaurav Das Gaiha · Massachusetts General Hospital · R01 · FY2024 · AI
Pediatric AIDS Clinical Trials Group
$859,411University Of California San Diego · U01 · FY2002 · AI
The regulatory role of natural progesterone in barrier immunity
$859,361Florian Hladik · University Of Washington · R01 · FY2025 · AI
ADOLESCENT MEDICINE TRIAL NETWORK FOR HIV/AIDS
$859,361Children'S Hospital Los Angeles · U01 · FY2003 · HD
Using monoclonal antibody Fc variants in strategies to eliminate HIV reservoirs
$859,353Ann Jones Hessell · Oregon Health & Science University · R01 · FY2021 · AI
Strategies for Providing Antiretroviral Therapy to Infants Shortly After Primary
$859,320Avy Violari · Wits Health Consortium (Pty), Ltd · U19 · FY2007 · AI
Peer-driven Intervention to Seek, Test & Treat Heterosexuals at High Risk for HIV
$859,317Marya Gwadz · New York University · R01 · FY2011 · DA
TOPICAL MICROBICIDES &BIOLOGY OF VENEREAL PATHOGENS
$859,231University Of Texas Medical Br Galveston · P01 · FY2001 · AI
HIV and musculoskeletal frailty: implications for care, policy and research
$859,206Elena Losina · Brigham And Women'S Hospital · R01 · FY2023 · NR
Core A: Administrative Core
$859,189Alan Edward Greenberg · George Washington University · P30 · FY2019 · AI
PROTECTIVE MECHANISMS WITH ATTENUATED LENTIVIRAL VACCINE
$859,182University Of California Davis · R01 · FY2001 · AI
Administrative Core
$859,161Alice Telesnitsky · University Of Michigan At Ann Arbor · U54 · FY2017 · GM